Resources from the same session
LBA88 - Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial
Presenter: Yihebali Chi
Session: Mini Oral - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
LBA89 - A randomized multicentered phase III study to evaluate apatinib in subjects with locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer
Presenter: Yansong Lin
Session: Mini Oral - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1914MO - Randomized phase II study of radiation therapy and paclitaxel with pazopanib or placebo: NRG-RTOG 0912
Presenter: Eric Sherman
Session: Mini Oral - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1158MO - Metabolomic profile of advanced neuroendocrine cancer patients
Presenter: Beatriz Soldevilla
Session: Mini Oral - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1159MO - Survival and prognostic factors analysis of 535 grade 3 gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN): Data from the Spanish Taskforce of Neuroendocrine Tumours Registry (R-GETNE)
Presenter: Paula Jimenez Fonseca
Session: Mini Oral - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1166MO - Clinical evaluation of serum succinate levels as a new biomarker in SDH-related paragangliomas and pheochromocytomas
Presenter: Constance Lamy
Session: Mini Oral - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1161MO - Lanreotide autogel (LAN) and temozolomide (TMZ) combination therapy in progressive thoracic neuroendocrine tumours (TNETs): ATLANT study results
Presenter: Piero Ferolla
Session: Mini Oral - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1162MO - Efficacy and safety of lanreotide autogel (LAN) 120 mg every 14 days in progressive pancreatic or midgut neuroendocrine tumours (NETs): CLARINET FORTE study results
Presenter: Marianne Pavel
Session: Mini Oral - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA88, LBA89 and 1914MO
Presenter: Enrique Grande
Session: Mini Oral - NETs and endocrine tumours
Resources:
Slides
Webcast
Invited Discussant 1158MO, 1159MO and 1166MO
Presenter: Christina Thirlwell
Session: Mini Oral - NETs and endocrine tumours
Resources:
Slides
Webcast